These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 25376228)
1. Elevated fecal M2-pyruvate kinase in children with cystic fibrosis: a clue to the increased risk of intestinal malignancy in adulthood? Pang T; Leach ST; Katz T; Jaffe A; Day AS; Ooi CY J Gastroenterol Hepatol; 2015 May; 30(5):866-71. PubMed ID: 25376228 [TBL] [Abstract][Full Text] [Related]
2. Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10years old. Garg M; Leach ST; Pang T; Needham B; Coffey MJ; Katz T; Strachan R; Widger J; Field P; Belessis Y; Chuang S; Day AS; Jaffe A; Ooi CY J Cyst Fibros; 2018 Jan; 17(1):109-113. PubMed ID: 28754328 [TBL] [Abstract][Full Text] [Related]
3. Intestinal inflammation and impact on growth in children with cystic fibrosis. Dhaliwal J; Leach S; Katz T; Nahidi L; Pang T; Lee JM; Strachan R; Day AS; Jaffe A; Ooi CY J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):521-6. PubMed ID: 25539196 [TBL] [Abstract][Full Text] [Related]
4. Fecal Human β-Defensin 2 in Children with Cystic Fibrosis: Is There a Diminished Intestinal Innate Immune Response? Ooi CY; Pang T; Leach ST; Katz T; Day AS; Jaffe A Dig Dis Sci; 2015 Oct; 60(10):2946-52. PubMed ID: 26271615 [TBL] [Abstract][Full Text] [Related]
15. Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders. Jeffery J; Lewis SJ; Ayling RM Inflamm Bowel Dis; 2009 Nov; 15(11):1630-4. PubMed ID: 19462434 [TBL] [Abstract][Full Text] [Related]
16. Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years. Ellemunter H; Engelhardt A; Schüller K; Steinkamp G J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):438-442. PubMed ID: 28207476 [TBL] [Abstract][Full Text] [Related]
17. Intestinal lesions are associated with altered intestinal microbiome and are more frequent in children and young adults with cystic fibrosis and cirrhosis. Flass T; Tong S; Frank DN; Wagner BD; Robertson CE; Kotter CV; Sokol RJ; Zemanick E; Accurso F; Hoffenberg EJ; Narkewicz MR PLoS One; 2015; 10(2):e0116967. PubMed ID: 25658710 [TBL] [Abstract][Full Text] [Related]
18. Accuracies of fecal calprotectin, lactoferrin, M2-pyruvate kinase, neopterin and zonulin to predict the response to infliximab in ulcerative colitis. Frin AC; Filippi J; Boschetti G; Flourie B; Drai J; Ferrari P; Hebuterne X; Nancey S Dig Liver Dis; 2017 Jan; 49(1):11-16. PubMed ID: 27693318 [TBL] [Abstract][Full Text] [Related]
19. Severe disease in Cystic Fibrosis and fecal calprotectin levels. Parisi GF; Papale M; Rotolo N; Aloisio D; Tardino L; Scuderi MG; Di Benedetto V; Nenna R; Midulla F; Leonardi S Immunobiology; 2017 Mar; 222(3):582-586. PubMed ID: 28012584 [TBL] [Abstract][Full Text] [Related]